These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 28447193)

  • 1. Ebola and Marburg virus vaccines.
    Reynolds P; Marzi A
    Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
    Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
    J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
    PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Immunogenicity of a Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine in Cynomolgus Macaques.
    Camargos VN; Rossi SL; Juelich TL; Smith JK; Vasilakis N; Freiberg AN; Nichols R; Fusco J
    Viruses; 2024 Jul; 16(8):. PubMed ID: 39205155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
    Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
    Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
    Warfield KL; Olinger GG
    J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
    Flaxman A; Sebastian S; Appelberg S; Cha KM; Ulaszewska M; Purushotham J; Gilbride C; Sharpe H; Spencer AJ; Bibi S; Wright D; Schmidt I; Dowall S; Easterbrook L; Findlay-Wilson S; Gilbert S; Mirazimi A; Lambe T
    PLoS Pathog; 2024 Jun; 20(6):e1012262. PubMed ID: 38924060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ebola and Marburg viruses: the humans strike back].
    Alazard-Dany N; Ottmann Terrangle M; Volchkov V
    Med Sci (Paris); 2006 Apr; 22(4):405-10. PubMed ID: 16597410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
    Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for immunisation against Marburg and Ebola viruses.
    Geisbert TW; Bausch DG; Feldmann H
    Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection.
    Warfield KL; Swenson DL; Negley DL; Schmaljohn AL; Aman MJ; Bavari S
    Vaccine; 2004 Sep; 22(25-26):3495-502. PubMed ID: 15308377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in filovirus vaccine development: evaluating the potential for clinical use.
    Falzarano D; Geisbert TW; Feldmann H
    Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of individual and combination DNA vaccines for B. anthracis, Ebola virus, Marburg virus and Venezuelan equine encephalitis virus.
    Riemenschneider J; Garrison A; Geisbert J; Jahrling P; Hevey M; Negley D; Schmaljohn A; Lee J; Hart MK; Vanderzanden L; Custer D; Bray M; Ruff A; Ivins B; Bassett A; Rossi C; Schmaljohn C
    Vaccine; 2003 Sep; 21(25-26):4071-80. PubMed ID: 12922144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
    Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.